| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/20/2013 | CN102525930B Lipoic acid liposome injection |
| 03/20/2013 | CN102443166B Process for synthesizing lactic acid-serine copolymer by catalyzing and carrying out ring-opening copolymerization on acetate bicyclo guanidine |
| 03/20/2013 | CN102441001B Compound allantoin vitamin B6-E and ammoniation ethyl sulfate eye drops and preparation method thereof |
| 03/20/2013 | CN102432774B Biodegradable temperature response hydrogel and preparation method thereof |
| 03/20/2013 | CN102430124B Pill coating with ultralow friction coefficient and preparation method thereof |
| 03/20/2013 | CN102370620B Pulmonic targeting immuno nano liposome and preparation method thereof |
| 03/20/2013 | CN102366409B Nizatidine liposome solid preparation |
| 03/20/2013 | CN102366408B Monosialotetrahexosyl ganglioside sodium liposome injection |
| 03/20/2013 | CN102366407B Clindamycin palmitate hydrochloride liposome solid preparation |
| 03/20/2013 | CN102357224B Aromatic pain-alleviating plaster |
| 03/20/2013 | CN102357093B Medicinal composition of methanesulfonic acid arbidol oral solid preparation |
| 03/20/2013 | CN102344151B Prussian blue nano-scale hollow olivary microballoons |
| 03/20/2013 | CN102335347B Panax pseudo-ginseng and panax quinquefolium soft capsules |
| 03/20/2013 | CN102327236B Esomeprazole sodium liposome injection |
| 03/20/2013 | CN102311478B Composite lipid comprising cholesterol group and application thereof |
| 03/20/2013 | CN102309534B Chinese medicinal herb composition for treating burns and scalds, its preparation method and application |
| 03/20/2013 | CN102302465B Tablet containing clopidogrel hydrogen sulfate and preparation method thereof |
| 03/20/2013 | CN102250365B PH-sensitive reduction responsive nanogel and preparation method thereof |
| 03/20/2013 | CN102247603B Infusion protein with transdermal drug delivery property |
| 03/20/2013 | CN102210734B Atractylis oil dripping pill and preparation method thereof |
| 03/20/2013 | CN102188495B Preparation method of Chilian oral liquid |
| 03/20/2013 | CN102144966B Preparation method of clindamycin phosphate injection |
| 03/20/2013 | CN102133235B Toad peptide antibiotic medicine for treating phthisis |
| 03/20/2013 | CN102105143B Stable pharmaceutical composition containing tranexamic acid and ascorbic acid |
| 03/20/2013 | CN102101888B Novel polypeptide for resisting tumors caused by EB (Epstein-Barr) viruses, and application and preparation method thereof |
| 03/20/2013 | CN102048843B Qingpeng emplastrum for reducing swelling and stopping pain and preparation method thereof |
| 03/20/2013 | CN102028801B Radix Rehmanniae oligosaccharide pulmonary delivery traditional Chinese medicinal preparation as well as preparation method and application thereof |
| 03/20/2013 | CN102008531B Fufukang gel and preparation method thereof |
| 03/20/2013 | CN101991590B Stilbene glucoside medical composition and preparation method thereof |
| 03/20/2013 | CN101959519B Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
| 03/20/2013 | CN101951922B Preparation for treating intestinal infection comprising oligosaccharides and insoluble cellular material |
| 03/20/2013 | CN101889023B Purification of PEGylated polypeptides |
| 03/20/2013 | CN101790387B Radiopharmaceutical composition |
| 03/20/2013 | CN101732347B Antler freeze-dried tablet and production method thereof |
| 03/20/2013 | CN101687819B Novel preparation for external use |
| 03/20/2013 | CN101674807B Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same |
| 03/20/2013 | CN101653422B Risperidone slow-release microsphere, preparation method and application thereof |
| 03/20/2013 | CN101623306B Bracken pill and preparation method thereof |
| 03/20/2013 | CN101522709B Pegylated PTH as PTH receptor modulators and uses thereof |
| 03/20/2013 | CN101505712B Compositions based on hyperbranched condensation polymers and novel hyperbranched condensation polymers |
| 03/20/2013 | CN101439017B Method for preparing polymer aqueous solution formulation of taxane anti-tumor medicament |
| 03/20/2013 | CN101411748B Salvia root total phenolic acid tablet and preparation method thereof |
| 03/20/2013 | CN101390831B Docetaxel medical composition for injection and preparation method thereof |
| 03/20/2013 | CN101384282B Method for production of a transformed cell |
| 03/20/2013 | CN101312747B Anticoagulant antithrombotic dual inhibitors comprising a biotin label |
| 03/20/2013 | CN101247837B Novel salts of conjugated psychotropic drugs and processes of preparing same |
| 03/20/2013 | CA2783359A1 Opioid peptide esters and methods of use |
| 03/19/2013 | US8399696 Functionalized biodegradable triclosan monomers and oligomers for controlled release |
| 03/19/2013 | US8399525 Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers |
| 03/19/2013 | US8399524 Acyl acidic amino acid ester |
| 03/19/2013 | US8399523 Quarternization of the additive amino alkylmethacrylate copolymer E for improving permeability and solubility of pharmaceuticals |
| 03/19/2013 | US8399431 Cyclodextrin-based polymers for therapeutics delivery |
| 03/19/2013 | US8399016 Sustained-release tablet composition of pramipexole |
| 03/19/2013 | US8399014 Physiologically active complex comprising protamine and/or salt therefor and an acidic macromolecular substance, and use thereof |
| 03/19/2013 | US8399009 Bioceramic and biopolymer composite |
| 03/19/2013 | US8398963 Cosmetic agent |
| 03/19/2013 | CA2738064C Pegylation of recombinant blood coagulation factors in the presence of bound antibodies |
| 03/19/2013 | CA2549041C Consumer customized dosage forms |
| 03/19/2013 | CA2534313C Formulations containing an immune response modifier |
| 03/19/2013 | CA2488499C Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"),combinations thereof as well as manufacturing of these pharmaceutical compositions |
| 03/19/2013 | CA2471702C Human monoclonal antibodies against cd30 |
| 03/14/2013 | WO2013036914A1 Materials and methods for modulating immune responses |
| 03/14/2013 | WO2013036847A1 Hydrogels with biodegradable crosslinking |
| 03/14/2013 | WO2013036775A1 Silicone coated implants |
| 03/14/2013 | WO2013036743A1 Imaging agents for imaging protease activity and uses thereof |
| 03/14/2013 | WO2013036383A1 Oral delivery for hemoglobin based oxygen carriers |
| 03/14/2013 | WO2013036296A1 Compositions and methods for producing antigen-specific induced tolerogenic dendritic cells with synthetic nanocarriers |
| 03/14/2013 | WO2013036213A1 Dpp-iv inhibitor formulations |
| 03/14/2013 | WO2013036032A1 A pharmaceutical composition for treating cancer, comprising interferon alpha conjugate |
| 03/14/2013 | WO2013035850A1 Transdermal preparation |
| 03/14/2013 | WO2013035837A1 Method for suppressing decrease in viscosity of aqueous liquid agent |
| 03/14/2013 | WO2013035757A1 Preparation comprising hexose-6-phosphate-modified cholesterol derivative |
| 03/14/2013 | WO2013035641A1 Method for manufacturing block copolymer |
| 03/14/2013 | WO2013035579A1 Liver-accumulative nanoparticle having drug encapsulated therein |
| 03/14/2013 | WO2013035423A1 Pharmaceutical composition containing candesartan cilexetil |
| 03/14/2013 | WO2013035113A1 Coated suppositories |
| 03/14/2013 | WO2013035101A1 Compositions of functional mitochondria and uses thereof |
| 03/14/2013 | WO2013034741A1 Nanoparticle tumour vaccines |
| 03/14/2013 | WO2013034726A1 Nanoparticle-peptide compositions |
| 03/14/2013 | WO2013034436A1 Pharmaceutical composition for oral administration with a statin |
| 03/14/2013 | WO2013034116A1 Vascular endothelial myostatin mutant that mutates at atp binding sites |
| 03/14/2013 | WO2013034040A1 Celecoxib solid dispersion and preparation method therefor |
| 03/14/2013 | WO2013033838A1 Liposomal formulations of cationic peptides and uses thereof |
| 03/14/2013 | WO2013033815A1 Cellulosic gel material as a pharmaceutical excipient |
| 03/14/2013 | WO2012177986A3 Conjugate-based antifungal and antibacterial prodrugs |
| 03/14/2013 | WO2012173422A9 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof |
| 03/14/2013 | WO2012173392A3 Curcuminoid-based compound/stevioside-containing complex for the prevention and treatment of an influenza virus infection |
| 03/14/2013 | WO2012153186A3 Monoclonal antibodies to epcam-icd and methods for detecting epithelial cancer cells |
| 03/14/2013 | WO2012149393A3 Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells |
| 03/14/2013 | WO2012149282A3 Tolerogenic synthetic nanocarriers for generating cd8+regulatory t cells |
| 03/14/2013 | WO2012149252A3 Tolerogenic synthetic nanocarriers |
| 03/14/2013 | WO2012149198A3 A method for manufacturing pegylated oligonucleotides |
| 03/14/2013 | WO2012141674A3 Compositions and methods relating to argininosuccinate synthetase |
| 03/14/2013 | WO2012135854A3 T cell receptor-like antibodies specific for a wt1 peptide presented by hla-a2 |
| 03/14/2013 | WO2012127277A3 Bendamustine anionic-catioinic cyclopolysaccharide compositions |
| 03/14/2013 | WO2012122313A3 Targeted nanocarrier systems for delivery of actives across biological membranes |
| 03/14/2013 | WO2012104655A3 Compostions and methods for treating chronic inflammation and inflammatory diseases |
| 03/14/2013 | US20130065971 Method for Lowering pH Using Urea Sulfate in the Presence of Corrosion Inhibitor |
| 03/14/2013 | US20130065968 Gel production apparatus and gel production method |
| 03/14/2013 | US20130065885 Oral therapeutic compound delivery system |